I am a
Home I AM A Search Login

Papers of the Week

Papers: 17 Oct 2020 - 23 Oct 2020

Pharmacology/Drug Development

2020 Oct 15



Pain modulatory properties of Phoneutria nigriventer crude venom and derived peptides: A double-edged sword.


Santana Sales Lauria P, Villarreal C F, Casais-E-Silva L L
Toxicon. 2020 Oct 15; 185:120-128.
PMID: 32668276.


Phoneutria nigriventer venom (PNV) is a complex mixture of toxins exerting multiple pharmacological effects that ultimately result in severe local pain at the site of the bite. It has been proposed that the PNV-induced pain is mediated by both peripheral and central mechanisms. The nociception triggered by PNV is peripherally mediated by the activation of B, 5-HT, NMDA, AMPA, NK, and NK receptors, as well as TTXS-Na, ASIC, and TRPV1 channels. The activation of tachykinin, glutamate and CGRP receptors along with the production of inflammatory mediators are, at least partially, responsible for the central component of pain. Despite its well established pro-nociceptive properties, PNV contains some toxins with antinociceptive activity, which have been studied in the last few years. The toxins ω-CNTX-Pn4a, ω-CNTX-Pn2a, ω-CNTX-Pn3a, κ-CNTX-Pn1a, U-CNTX-Pn1a, δ-CNTX-Pn1a, and Γ-CNTX-Pn1a from PNV, as well as the semi-synthetic peptide PnPP-19 have been tested in different experimental models of pain showing consistent antinociceptive properties. This review aims to discuss the pro- and antinociceptive actions of PNV and its toxins, highlighting possible mechanisms involved in these apparently dualistic properties.